T
AMED

TCWP’s Amedisys AMED Stock Holding History

TCWP’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14
Closed -$2K – 326
2022
Q1 		$2K Buy
+14
New +$2.09K ﹤0.01% 1273

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

TCWP's AMED Position: Q2 2022 in Review

TCWP sold out of Amedisys (AMED) in Q2 2022, closing a stake of 14 shares — an estimated $2K sold.

TCWP first reported a position in AMED in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • TCWP reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 14 Amedisys shares in Q2 2022, an estimated $2K.
  • TCWP first reported a position in Amedisys in Q1 2022 and held it in 1 quarter.
  • TCWP's Amedisys position peaked at $2K in Q1 2022.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.